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p < 0.001) in response to the whey protein supplement. The 
percent increase in  Ki and FSR in response to the whey 
protein supplement was significantly correlated (r = 0.79, 
p = 0.015).
Conclusions Dynamic PET/CT imaging with 11C-MET 
provides an estimate of the post-prandial anabolic response 
that is consistent with a traditional, invasive stable isotope, 
and muscle biopsy approach. These results support the 
potential future use of 11C-MET imaging as a non-invasive 
method for assessing conditions affecting skeletal muscle 
protein synthesis.
Keywords PET/CT · Human · Muscle protein synthesis · 
FSR
Abbreviations
FSR  Fractional synthetic rate
Ki  Patlak Coefficient, representing fractional 
extraction rate Ki from plasma into a periph-
eral compartment (bound protein)
13C-Phe  L- [ring-13C6] phenylalanine
PET  Positron emission tomography
11C-MET  11C-L-methyl-methionine
MPS  Muscle protein synthesis
PSR  Protein synthetic rate
CT  Computed tomography
IDIF  Image-derived input function
TAC  Tissue activity curve
CA  Activity of 11 C-MET measured in femoral 
artery by IDIF analysis
CT  Activity of 11 C-MET measured in skeletal 
muscle tissue at each point in the TAC
Abstract 
Objective The objective of this study was to determine 
if clinical dynamic PET/CT imaging with 11C-L-methyl-
methionine (11C-MET) in healthy older women can pro-
vide an estimate of tissue-level post-absorptive and post-
prandial skeletal muscle protein synthesis that is consistent 
with the more traditional method of calculating fractional 
synthesis rate (FSR) of muscle protein synthesis from skel-
etal muscle biopsies obtained during an infusion of L-[ring 
13C6] phenylalanine (13C6-Phe).
Methods Healthy older women (73 ± 5 years) completed 
both dynamic PET/CT imaging with 11C-MET and a sta-
ble isotope infusion of 13C6-Phe with biopsies to measure 
the skeletal muscle protein synthetic response to 25  g of 
a whey protein supplement. Graphical estimation of the 
Patlak coefficient  Ki from analysis of the dynamic PET/
CT images was employed as a measure of incorporation of 
11 C-MET in the mid-thigh muscle bundle.
Results Post-prandial values [mean ± standard error of 
the mean (SEM)] were higher than post-absorptive val-
ues for both  Ki (0.0095 ± 0.001 vs. 0.00785 ± 0.001 min−1, 
p < 0.05) and FSR (0.083 ± 0.008 vs. 0.049 ± 0.006%/h, 
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Introduction
Muscle-wasting conditions place a significant burden on 
the public health system and are a threat to independence 
and quality of life [1, 2]. Our ability to develop pharma-
cologic, nutritional, or exercise based countermeasures to 
muscle/function loss is intrinsically tied to the availabil-
ity of quantitative methods to characterize their effects on 
the physical and biochemical properties of skeletal muscle 
tissue.
In research environments, the measurement of acute 
localized skeletal muscle protein fractional synthesis rate 
(FSR) is traditionally used to quantify the response to an 
anabolic stimulus [3, 4]. This moderately invasive proce-
dure includes a stable isotope infusion (e.g., L- [ring-13C6] 
phenylalanine (13C-Phe)), peripheral venous blood sam-
pling, and serial needle muscle biopsies, typically from 
the vastus lateralis. The stable isotope, 3-pool modeling 
technique provides an estimate of protein synthesis and 
breakdown, but requires femoral venous and arterial cath-
eterization [5]. While these methodologies continue to be 
used successfully in a variety of clinical research environ-
ments [6, 7], they may be contraindicated for clinically 
vulnerable populations. Thus, a technology to rapidly and 
non-invasively evaluate skeletal muscle protein anabolism 
would have significant impact on the assessment of muscle-
wasting and associated countermeasures in people unable 
to tolerate prolonged, more invasive studies.
In the late 1990s, Fischman and colleagues [8] intro-
duced dynamic positron emission tomography (PET) imag-
ing of skeletal muscle [8, 9]. They combined an infusion 
of 11C-L-Methyl-Methionine (11C-MET) with three com-
partment kinetic modeling to provide a minimally invasive, 
in vivo estimate of skeletal muscle protein synthesis (MPS) 
in potentially any muscle bed, at any anatomic site. An ani-
mal study demonstrated that uptake of 11C-MET in skeletal 
muscle is highly correlated with its stable isotope analog 
(13C-L-Methyl-Methionine) [9], and basal (i.e., fasted and 
resting) kinetic model parameters have successfully been 
evaluated in adult humans [8]. However, until recently, 
there were no data evaluating the ability of PET imaging to 
quantify MPS changes in response to known anabolic stim-
uli. In 2012, Harnish et al. showed that 11C-MET responded 
to the anabolic stimulus of exercise-induced muscle fatigue 
[10]. In this study of unilateral knee extension and flexion, 
11C-MET uptake was increased 1-h post-exercise in the 
exercised compared to the control leg. This was reflected 
in a side-to-side difference in the Patlak Coefficient (Ki), a 
measure of forward extraction of the imaging agent into the 
skeletal muscle protein compartment [10].
The studies referenced above support the potential to use 
non-invasive imaging methodology to assess the anabolic 
response of skeletal muscle to clinically relevant nutritional 
and pharmacologic interventions used to treat skeletal mus-
cle atrophy in patient groups such as sarcopenic elderly, and 
patients with muscle-wasting conditions such as chronic 
kidney disease, HIV, or diabetes. However, to be considered 
for evaluation of MPS in these populations, it is important 
to show that measures derived from imaging correlate with 
information coming from gold standard techniques such as 
13C-Phe infusion/biopsy. Although PET/CT and stable iso-
tope infusion/biopsies use different tracers (11C-MET and 
13C-Phe) to measure  Ki and FSR, respectively, both meth-
odologies effectively target the biological process of pro-
tein synthesis by quantifying the incorporation of an iso-
topically labeled amino acid into the skeletal muscle tissue. 
Therefore, the goal of this study was to determine feasibil-
ity of clinical dynamic PET/CT imaging with 11C-MET in 
healthy older women to provide an estimate of tissue-level 
post-absorptive and post-prandial skeletal MPS that is con-
sistent with FSR calculated from skeletal muscle biopsies 
obtained during an infusion of 13C-Phe. We chose to use 
older women for this current study, because they tend to 
be at high risk for sarcopenia [11], but are anecdotally less 
likely to volunteer for biopsy studies and are more difficult 
to biopsy because of lower lean mass, making them a pop-
ulation that would benefit from the development of non-
invasive methodology.
Materials and methods
Subjects
Healthy, community-dwelling, post-menopausal, tracer 
naïve women aged 66–80 years (average age 73 ± 5 years; 
n = 13) were recruited from the greater San Francisco Bay 
Area. Study protocols and procedures were conducted in 
accordance with the Declaration of Helsinki and reviewed 
and approved by the Institutional Review Board of the Uni-
versity of California San Francisco (UCSF). After provid-
ing written informed consent, volunteers were medically 
screened in the UCSF Clinical Research Center (CRC). 
Subjects were excluded if they had been diagnosed with 
any musculoskeletal or metabolic disease, including diabe-
tes, uncontrolled hypertension, or autoimmune disease, as 
previously described [12].
Procedures
All subjects completed three study visits in sequential 
order, with each visit separated by 1–2 weeks. The pro-
tocols to measure changes in  Ki (PET/CT) required two 
imaging visits, one in which the subjects were imaged after 
an overnight fast (water only) and one in which the subjects 
arrived in the fasting state and then consumed a 25-g whey 
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protein isolate supplement (BiPro, Davisco, Le Sueur, MN) 
1 h prior to imaging. The FSR (muscle biopsy) protocol 
involved an infusion of 13C-Phe during which biopsies were 
obtained immediately before and 2 h after ingestion of the 
whey protein supplement. The timing of the imaging and 
infusion biopsy protocols is summarized in Fig. 1.
PET/CT image acquisition
For the imaging visits, subjects reported to the China 
Basin Outpatient Imaging Center at the UCSF Depart-
ment of Radiology and Biomedical Imaging. All images 
were acquired using a Discovery VCT PET/CT camera 
(GE Healthcare, Chicago, IL, USA). Subject was oriented 
in the scanner in the supine position, with legs extended 
into the scanner aperture and feet straight up and taped 
together. An anteroposterior scout view depicted the lower 
body anatomy from the iliac crest to the tibial plateau and 
was employed to determine a CT scanning interval from 
the mid-thigh to a point roughly 2-cm superior to the dis-
tal femoral condyle. The dynamic PET axial field of view, 
which extended 14.5  cm along the table axis (the fixed 
width of the PET detector array), was centered in the CT 
volume. Based on the CT scan volume defined from the 
scout view, the subject was imaged with a helical CT scan 
(120 kVp, 300 mAs, 3.75-mm sections,  5122 matrix, and 
standard reconstruction kernel). After the CT image was 
acquired, the subject was injected with a bolus of 462-
MBq (range 407–481  MBq) 11C-MET solution, resulting 
in an approximately 2-mSv effective dose to the subjects. 
Beginning concurrently with the 11C-MET bolus injec-
tion, the dynamic PET data were acquired using a sequence 
of 27 temporally contiguous frames over the course of 
60  min. The time frames were of variable durations, 
acquired in the following sequence: [15 × 10  s, 5 × 30  s, 
4 × 5  min, 2 × 10  min, 1 × 15  min]. Images were recon-
structed into voxels of dimensions 1.95 × 1.95 × 3.27  mm3 
in 256 × 256 × 47 matrices via a 3D ordered subset expec-
tation maximization algorithm (28 subsets, two iterations) 
with CT-based attenuation correction provided by the scan-
ner manufacturer.
PET/CT image analysis
To determine the rate of incorporation of 11C-MET into 
bound skeletal muscle protein, we employed the Patlak 
graphical analysis [13], which can be used to determine the 
fractional extraction rate Ki from plasma into a peripheral 
compartment (bound protein). The method assumes that the 
tissue compartment is in rapid equilibrium with the plasma 
and bound peripheral compartments, and that release from 
the bound compartment is not observed in the timescale of 
the study. To derive Ki from the dynamic images, the ratio 
CT(t)/CA(t) is plotted against ∫CA(t)dt/CA(t), integrated 
between t = 0 and t = 60 min, where CA(t) is the concentra-
tion as a function of time t of the tracer 11C-MET in the 
femoral artery as represented by the image-derived input 
function (IDIF, see below), and CT(t) is the concentration 
as a function of time measured in the tissue activity curve 
(TAC). When the system achieves equilibrium between the 
three compartments, the Patlak plot becomes linear and the 
Patlak slope  Ki can be derived from fitting that linear com-
ponent. In a previous study [10], we reported a high cor-
relation (r = 0.92) between Ki and the MPS rate estimated 
by Fishman et  al. [8] from kinetic analysis using a three 
compartment model of dynamic PET data. Because of the 
robustness and simplicity of the Patlak Ki, we utilized it as 
a measure of image-derived MPS in this study.
To estimate the contribution of arterial blood flow to the 
skeletal muscle uptake of 11C-MET as a function of time 
Fig. 1  Study time-lines. Visit 1 
Assessment of post-absorptive 
MPS using PET/CT with a 11C-
MET bolus. Visit 2 Assessment 
of post-prandial MPS using 
PET/CT. Visit 3 Assessment 
of post-absorptive and post-
prandial FSR using 13C-Phe and 
muscle biopsies. All visits were 
separated by 1–2 weeks
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CA(t), we computed an image-derived arterial input func-
tion (IDIF) from region of interest analysis around the fem-
oral artery as previously described [14]. The implementa-
tion of the IDIF for analysis of the dynamic images in our 
study was described by Harnish et al. [10]. To quantify the 
uptake of 11C-MET in skeletal muscle, 11C-MET concen-
trations were measured from regions of interest (ROIs) 
determined automatically from the CT scans using thresh-
old-driven region growing. The distal femoral condyle and 
the lesser trochanter, two bony landmarks visible on the 
anteroposterior scout view, were used to establish the infe-
rior and superior limits of the set of axial slices included 
in the TAC ROI. The inferior limit of the ROI occurred in 
the axial slice closest to 36% of the distance from the femo-
ral condyle to the lesser trochanter, and the superior limit 
occurred in the slice closest to 44% of that distance. To 
avoid contamination of the tissue region by arterial counts, 
a region surrounding the artery, roughly the extent of the 
outer radius of the annular region used to subtract tissue 
background counts from the arterial signal, was excluded 
from the skeletal muscle tissue ROI. Representative PET/
CT images and the region used for derivation of the arterial 
input function are shown in Fig. 2.
Stable isotope and biopsy methodology
1–2 weeks after the completion of the first imaging 
visit, volunteers were admitted to the UCSF-CRC. An 
18-gauge polyethylene catheter (Insyte-W; Becton Dick-
inson, Sandy, UT) was inserted into the forearm vein of 
each arm, one for blood sampling, and one for stable iso-
tope infusion. After baseline blood sampling to measure 
background phenylalanine enrichment, a primed (2 μmol/
kg), constant infusion (0.06  μmol/kg/min) of L- [ring-
13C6] phenylalanine was started and continued throughout 
the study (Fig. 1). A 5-mm Bergstrom needle was used to 
take a muscle biopsy from the vastus lateralis under local 
anesthesia following a standardized technique [4]. Sub-
jects ingested 25 g of whey protein mixed with 250 mL 
of water immediately following the second biopsy. This 
high-quality protein has been shown to provide a rapid, 
near maximal increase in skeletal muscle protein synthe-
sis [15]. Peripheral venous blood samples and the final 
muscle biopsy were obtained according to the schedule 
outlined in Fig. 1.
Processing of blood and skeletal muscle samples
Venous blood samples were immediately mixed with 
1 mL ice-cold sulfosalicylic acid and centrifuged for 
20 min (3000 rpm at 4 °C). The supernatant was removed 
and stored at -80 °C. Muscle samples were blotted and 
rinsed with saline, flash frozen in liquid nitrogen, and 
stored at −80 °C. All muscle and blood samples were sent 
to the University of Texas Medical Branch for analysis. 
Phenylalanine enrichment of muscle proteins as well as 
plasma were determined as previously described [7, 12].
Mixed muscle fractional synthesis rate was calculated 
by measuring the direct incorporation of 13C6-Phe into 
protein using the precursor-product model [7]:
where EB is the protein-bound phenylalanine enrich-
ment across two sequential biopsies taken at time T1 and 
T2, respectively, and EP is the adjusted plasma enrich-
ment obtained by dividing venous 13C-Phe enrichment 
area under the curve between sequential biopsies with the 
average venous enrichment at each biopsy, as previously 
described [15, 16]. This adjustment reduces the potential 
for erroneous underestimation of the post-prandial FSR 
associated with the depression of plasma phenylalanine 
enrichment.
FSR =
[EB(t2) − EB(t1)]
[t2 − t1]
∕
[Ep(t1) + Ep(t2)]
2
× 60 × 100
Fig. 2  Images from Subject 004. CT (a) and PET (b) images cor-
responding to central mid-thigh cross section of thigh volume. The 
fused PET/CT image is shown in (c). The tissue activity curve (TAC) 
was computed from the region encompassing the total thigh muscle 
volume, but excluding bone and the region used to determine the 
image-derived input function (IDIF). These regions are superimposed 
in gold pixels on all three images
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Statistical analysis
The anabolic response measured with both PET/CT and 
stable isotope infusion was analyzed using a paired two-tail 
student t test with a significant difference set at p < 0.05. 
Data are presented with the average ± standard error of the 
mean (SEM). The relationship between baseline Ki and 
FSR, and between the percent increases in  Ki and FSR, 
measured by PET/CT and stable isotope, respectively, was 
evaluated using a Pearson correlation. Statistical analyses 
were performed using the JMP software (Cary, NC).
Based on preliminary work from our group, we expected 
to be able to detect a significant, 30% increase in Ki with 
80% power with a sample size of 12 subjects. Thirteen sub-
jects were recruited for the study, and one subject dropped 
out of the study after the first imaging visit and was not 
included in any analysis. Out of the 12 subjects that com-
pleted all 3 study visits, 1 subject had invalid post-prandial 
Ki measurement, because the tissue activity curve did not 
saturate during the course of the imaging study and was not 
included in the analysis of Ki. Furthermore, two subjects 
had unusable biopsy samples due to a high amount of fat 
and were excluded from the FSR analysis. Therefore, nine 
subjects had usable post-absorptive and post-prandial Ki 
and FSR data and were included in the correlation analysis.
Results
Baseline characteristics
Figure  3 shows post-absorptive and post-prandial arterial 
input and tissue activity curves and Fig.  4 shows Patlak 
plots for one of the study subjects (Subject 4). Table 1 pro-
vides demographic and post-absorptive and post-prandial 
 Ki and FSR values for the subjects. There was no cor-
relation between post-absorptive Ki and FSR (r = 0.12, 
p = 0.75).
Anabolic response
A 25  g whey protein supplement elicited a 20% increase 
and a 70% increase in Ki (Fig.  5a) and FSR (Fig.  5b), 
respectively. The post-absorptive and post-prandial as well 
the percent increase are consistent with the previous values 
reported in the literature [17]. The percent increase in  Ki 
and FSR in response to the whey protein supplement was 
significantly correlated (Fig. 6).
Discussion
The prevalence of sarcopenia and other clinical conditions 
are associated with muscle-wasting motivate the develop-
ment of strategies to reduce or prevent disability. The ulti-
mate goal of such therapies is the preservation/restoration 
of muscle mass and functional capacity.
Therefore, the ability to quantify acute changes in skel-
etal muscle protein synthesis is an essential prerequisite to 
understanding the potential clinical/practical relevance of 
anabolic therapies or interventions. In this study, we dem-
onstrated that 11C-MET PET/CT imaging shows an ana-
bolic response to a clinically relevant therapeutic approach, 
dietary protein supplementation, and that the response is 
correlated to 13C-Phe infusion biopsy. Thus, we provided 
new evidence that a non-invasive quantitative imaging 
approach can provide valuable new information to assess 
Fig. 3  Overlay of post-absorptive and post-prandial image-derived 
input function IDIF (left vertical axis) and tissue activity curve (TAC) 
(right vertical axis) obtained for Subject 004
Fig. 4  Post-absorptive and post-prandial Patlak plots for Subject 004. 
Linear fits to linear portions of Patlak curves are overlaid on the data
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the potential effects of approaches to counter muscle 
atrophy.
The historic gold standard for assessing skeletal mus-
cle protein synthesis involves the infusion of a stable 
isotope labeled amino acid (e.g., 13C6- phenylalanine, 
L-[ring-2H5]phenylalanine, and L-[1-13C]leucine) cou-
pled with serial muscle biopsies along with peripheral 
vein and occasionally femoral artery and vein blood sam-
pling [5]. While this technique is sensitive and widely 
used, it has several limitations: (1) the quantity of tis-
sue obtained by biopsy is limited (50–100  mg /muscle 
biopsy); (2) not all muscle beds/sites can be safely or 
effectively biopsied; (3) the procedure is moderately 
invasive, involves some discomfort, and results in a small 
scar; (4) obtaining suitable quality and quantity of muscle 
Table 1  Demographic data, post-absorptive (pa) Ki and FSR data, and post-prandial (pp) Ki and FSR data for the individual subjects. Blank 
spaces correspond to missing values where PET/CT or infusion/biopsy measurements could not be completed
Ethnic composition of cohort: 7 Caucasian, 2 Asian, 2 African-American and 1 Hispanic 
Subject 
number
Age (years) Weight (kg) Height (cm) Ki (pa)  (min−1) Ki (pp)
(min−1)
FSR (pa) (%/h) FSR (pp) (%/h)
1 72 73 167.6 0.0065 0.0072 0.098 0.130
2 70 72 162.6 0.0088 0.0099 0.036 0.061
3 74 86 152.4 0.0071 0.0092 0.057 0.095
4 80 52 167.6 0.0052 0.0097 0.040 0.089
5 71 62 154.9 0.0126 0.0120 0.048 0.078
6 80 44 152.4 0.0068 0.0094
8 72 57 154.9 0.0090 0.0123 0.045 0.067
9 73 68 160.0 0.0089 0.0086 0.050 0.078
10 80 54 165.1 0.0058 0.0075 0.033 0.078
11 69 66 180.3 0.041 0.109
12 71 75 162.6 0.0074 0.0063
13 66 73 172.7 0.0084 0.0120 0.041 0.046
Fig. 5  Box and whiskers plot post-absorptive and post-prandial 
Ki (n = 11; a). Box and whiskers plots of post-absorptive and post-
prandial FSR (n = 10; b). For both plots, the box represents the inter-
quartile range containing 50% of the values. The whiskers denote the 
maximum and minimum values (excluding outliers). The link drawn 
across the box is the median. Both Ki and FSR significantly increased 
in response to a 25 g whey protein supplement
Fig. 6  Plot of the percent increase of FSR and  Ki in response to the 
25 g whey protein supplement based on nine subjects with complete 
post-absorptive and post-prandial Ki and FSR measurements
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tissue from sarcopenic, frail, and/or obese individuals is 
challenging; (5) quantifying a change in fractional syn-
thesis rate (FSR) requires at least two biopsies obtained 
over a 2–4-h period.
There are other methodologies that provide some insight 
into skeletal muscle response to anabolic therapies. Change 
in serum albumin is used as a crude clinical marker of 
muscle mass status [18]. Whole-body rate of appearance 
(Ra)/rate of disappearance (Rd) studies using stable iso-
topes are very useful in clinical populations, because they 
do not require biopsies [19]. However, the gut/splanchnic 
bed plays a dominant role in determining whole-body Ra/
Rd and, therefore, limits the ability to determine an iso-
lated skeletal muscle response. Deuterium-labeled water is 
a minimally invasive method of assessing whole-body pro-
tein turnover [20], but is not as specific as FSR, especially 
when measuring an acute anabolic response. Nitrogen bal-
ance studies are traditionally used for determining protein 
needs [21], but have limited clinical utility because of the 
complexity and time-intensive nature of the method.
Imaging approaches such as 11C-MET PET/CT imaging 
offer some time savings and clinical advantages. Unlike a 
traditional stable isotope-based infusion/biopsy process, in 
which two or more hours of the initial infusion are required 
to establish an isotopic steady state, the imaging approach 
requires roughly 1 h to obtain a set of image frames that 
can be analyzed to obtain the Patlak coefficient, which 
describes the forward transport and capture of the 11C from 
the blood pool into the muscle tissue bed. While other 
techniques such as the stable isotope pulse bolus technique 
are shorter than the traditional infusion protocol, it is not 
designed to measure the response to an anabolic stimulus 
[22]. In addition to time savings, PET/CT imaging is less 
invasive, and involves considerably less discomfort than 
serial skeletal muscle biopsies. Furthermore, the 11C-MET 
PET/CT approach can be carried out by a nuclear medicine 
technologist and does not require skilled nursing and physi-
cian support to perform the injection and imaging. Finally, 
the 11C-MET PET/CT image, as acquired in our study, pro-
vided a 3D map of 11C-MET uptake in a 14-cm thick vol-
ume of the thigh imaged as a stack of slices with 3.75-mm 
thickness. Compared to the biopsy of the vastus lateralis, 
this allowed us to average the  Ki value over a large tissue 
volume, reducing susceptibility to tissue sampling varia-
tions. Because of this capability, PET/CT provides func-
tional information about the general distribution of an ana-
bolic response across an entire limb containing an array of 
different functional muscle groups that must operate syner-
gistically. Our findings suggest that PET/CT imaging may 
function synergistically with biopsy, by focusing the use of 
the biopsy sample for the purposes for which it is uniquely 
suited, for example for studies of myofibrillar structure or 
of gene expression.
However, it is important to note that this approach has 
technical limitations as well as strengths. One limitation is 
that this type of study necessarily involves radiation expo-
sure due to the administration of 11C-MET. In our case, the 
total radiation exposure associated with the two PET/CT 
studies was approximately 4 mSv, which is equivalent to 
slightly more than 1 year of background exposure. Another 
limitation of the approach is that in contrast to biopsy 
methods, it is not possible, due to the limited imaging reso-
lution, to quantify 11C-MET uptake in particular compart-
ments of the skeletal muscle tissue, such as mitochondrial 
or myofibrillar protein. Thus, although it offers advantages 
in the rapidity of acquisition and reduced invasiveness, as 
well as ability to survey whole muscle beds, increases in 
11C-MET uptake represent a relatively crude measure of 
anabolic response of skeletal muscle tissue. In addition to 
technical limitations, there are also logistical and economic 
characteristics that should be considered. Although PET/
CT systems are widely distributed throughout the United 
States (≅1300 systems [23]), 11C-MET imaging requires 
access to an onsite cyclotron and radiochemistry facility, 
and thus tends to be limited to a smaller number academic 
medical centers. Thus, based on this combination of advan-
tages and limitations, we believe that at present, the pri-
mary utility of this approach is as a research tool, concen-
trated in academic medical centers where investigations of 
skeletal muscle function response are most likely to occur.
The current study is the first to show PET/CT imag-
ing of radio-labeled amino acids such as 11-C-MET has 
an acute skeletal muscle anabolic response to administra-
tion of dietary protein and that the extent of the response 
is correlated to that of the 13C-Phe infusion/biopsy meas-
urements, the gold standard. The previous literature has 
shown that 11C-MET uptake as measured by PET tracks 
with the accumulation of the 13  C labeled analog in ani-
mal necropsy models [9] and that reasonable values of 
PSR could be estimated in humans from PET images [8]. 
In a subsequent study using PET/CT, we showed that Ki, 
which is highly correlated to PSR, increased in relation to 
exercise in a unilateral leg resistance exercise model [10]. 
However, that study had limited clinical relevance, because 
anabolic therapies in sarcopenic subjects are likely to be 
pharmacologic or nutritional and because that study did not 
show correlation to a gold standard PSR measurement, sta-
ble isotope infusion of 13 C-phenyalanine with serial biop-
sies. The strength of this study was that it used a nutritional 
intervention known to result in increased protein synthesis 
rate, and compared changes in image-derived kinetics of 
11C-MET to changes in 13C-Phe kinetics using standard 
infusion/biopsy approach. We revealed that both techniques 
showed a significant elevation with the known anabolic 
stimulus and that the responses of the two approaches were 
correlated with statistical significance. Interestingly, despite 
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the correlation of percentage change measures, the base-
line values of Ki and FSR were uncorrelated. We believe 
that this may arise from differences in the functional roles 
of methionine and phenyalanine. While both are structural 
constituents of skeletal muscle protein, methionine is the 
only sulfur-containing amino acid and has important meta-
bolic and signaling roles [24, 25] apart from its structural 
role. Unlike phenyalanine, methionine is not produced in 
the body and must be obtained from external sources. Thus, 
because there may be inter-individual variations in MET 
metabolism due to these additional metabolic and signaling 
roles, skeletal muscle uptake of these two amino acids may 
be uncorrelated in the fasted state, but be correlated in their 
responses to a powerful anabolic stimulus that increases 
incorporation of all amino-acid constituents into skeletal 
muscle. In summary, from our current findings, and from 
the previous study showing 11C-MET response to exercise, 
we believe that that this imaging method shows a similar 
anabolic response of skeletal muscle tissue to anabolic 
interventions such as nutritional therapies, exercise, and 
pharmacologic interventions similarly to 13C-Phe infusion 
and serial biopsy.
While our study has strengths, and the results are 
strongly supportive of further exploration of this approach 
in larger studies, there are limitations to consider. The inter-
individual variability in Ki and in the change in Ki was 
higher than that observed for FSR. Furthermore, the cor-
relation obtained (r = 0.8) was somewhat low. This is not 
surprising, given that the number of subjects was small, the 
two imaging measurements were done on different days, 
the imaging and biopsy studies were also done separately, 
and they used different compounds for the MPS measure-
ments. Thus, our study does not establish that 11C-MET 
imaging is a surrogate measure for 13C-Phe infusion/biopsy 
study in individuals. However, we do believe that this 
approach demonstrates the feasibility of using the  Ki deter-
mination from 11C-MET imaging as a measure of skeletal 
muscle anabolic response in groups of subjects, and greatly 
supports the use of this technique as a research tool, par-
ticularly, as described below, in subjects who may not be 
able to sustain a prolonged infusion/biopsy study.
We believe that this approach will have advantages as a 
research tool, making dynamic assessment of skeletal mus-
cle anabolic response more accessible in the target popu-
lations expected for anabolic agents. We believe that this 
approach is best applied to investigations of health condi-
tions that have a deleterious effect on PSR, such as long-
term bed rest. For example, bed rest studies of healthy 
subjects show up to 30% decreases in PSR as measured by 
13C-Phe infusion and biopsy. People, especially the elderly, 
who may under undergo 2–3 weeks of bed rest for health 
conditions often suffer from sarcopenia [26–28], which 
complicates rehabilitation. Because this approach greatly 
reduces the time burden and discomfort for the patient, 
11C-MET imaging with PET/CT may be useful to charac-
terize skeletal muscle deficits in this population. By the 
same token, it will also be applicable to investigate skeletal 
muscle function in other disease groups, such as chronic 
kidney disease [29–31], HIV [32, 33] or diabetic patients 
[34–36]. Moreover, because the PET image is co-registered 
with a CT image, it is possible to correlate the  Ki measure 
with measures of muscle cross-sectional area and lean tis-
sue Hounsfield Unit, a measure of fatty infiltration which 
is associated with altered muscle strength and physical 
function.
In conclusion, PET/CT with 11C-MET can be used to 
represent the aggregate response of a group of subjects to 
conditions that stimulate or reduce protein synthesis. From 
the previous work, the  Ki responds to unilateral leg exten-
sion and flexion exercise, which stimulates protein synthe-
sis rate as measured in biopsy/infusion studies. From this 
work, there is a significant positive response to whey pro-
tein ingestion, which agrees with the aggregate response in 
our subjects by biopsy.
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